Cerebrospinal fluid nitrite and malondialdehyde levels in patients with motor neuron disease

International Journal of Neuroscience

Volumn 113, Issue 8, 2003, Pages 1043-1054

  Shukla, Rakesh ^a   Rajani, M ^a   Barthwal, M K ^b   Srivastava, N ^b   Dikshit, Madhu ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Cerebrospinal fluid; Motor neuron disease; Neurodegenerative diseases; Nitric oxide; Oxidative stress

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; NERVE DEGENERATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PATHOGENESIS;

ADULT; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MOTOR NEURON DISEASE; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; STATISTICS, NONPARAMETRIC;

EID: 0041695585     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450390212258     Document Type: Article

References (37)

1. Aoyama, K., Matsubara, K., Fujikawa, Y., Nagahiro, Y., Shimizu, K., Umegae, N., Hayase, N., Shiono, H., & Kobayashi, S. (2000). Nitration of manganese superoxide dismutase in cerebrospinal fluid is a marker for peroxynitrite mediated oxidative stress in neurodegenerative diseases. Annals of Neurology, 47(4), 524-527.
2. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990). Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proceedings of National Academy of Sciences USA, 87(4), 1620-1624.
3. Beckman, J. S., Carson, M., Smith, C. D., & Koppenol, W. H. (1993). ALS, SOD and peroxynitrite. Nature, 364(6438), 584.
4. Bonnefont-Rousselot, D., Lacomblez, L., Jaudon, M., Lepage, S., Salachas, F., Bensimon, G., Bizard, C., Doppler, V., Delattre, J., & Meininger, V. (2000). Blood oxidative stress in amyotrophic lateral sclerosis. Journal of Neurological Sciences, 178(1), 57-62.
5. Bredt, D. S., & Snyder, S. H. (1994). Nitric oxide: A physiological messenger molecule. Annual Review of Biochemistry, 63, 175-195.
6. Caroscio, J. T., Mulvihill, M. N., Sterling, R., & Abrams, B. (1987). Amyotrophic lateral sclerosis: Its natural history. Neurology Clinics, 5(1), 1-8.
7. Catania, M. V., Aronica, E., Yankaya, B., & Troost, D. (2001). Increased expression of neuronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord. Journal of Neurosciences, 21(11), RC 148.
8. Chabrier, P. E., Demerle-Pallardy, C., & Auguet, M. (1999). Nitric oxide synthases: Targets for therapeutic strategies in neurological disease. Cell Molecular Life Sciences, 55(8-9), 1029-1035.
9. Chou, S. M., Wang, H. S., & Komai, K. (1996). Colocalisation of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: An immuno-histochemical study. Journal of Chemical Neuroanatomy, 10(3-4), 249-258.
10. Eliasson, M. J., Blackshaw, S., Schell, M. J., & Snyder, S. H. (1997). Neuronal nitric oxide synthase alternatively spliced forms: Prominent functional localisations in the brain. Proceedings of National Academy of Sciences USA, 94(7), 3396-3401.
11. Green, M. H., Marcovitch, A. J., Harcourt, S. A., Lowe, J. E., Green, I. C., & Arlett, C. F. (1997). Hypersensitivity of ataxia telangiectasia fibroblasts to a nitric oxide donor. Free Radicals in Biology and Medicine, 22(1-2), 343-347.
12. Guevara, I., Iwanejko, J., Dembinska-Kiec, A., Pankiewicz, J., Wanat, A., Anna, P., Golabek, I., Bartus, S., Malczewska-Malec, M., & Szczudlik, A. (1998). Determination of nitrite/nitrate in human biological material by simple Griess reaction. Clinica Chimica Acta, 27(2), 177-188.
13. Halliwell, B. (1992). Reactive oxygen species and the central nervous system. Journal of Neurochemistry, 59(5), 1609-1623.
14. Ikeda, M., Sato, I., Yuasa, T., Miyatake, T., & Murota, S. (1995). Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurological diseases. Journal of Neural Transmission, 100(3), 263-267.
15. Jaffery, S. R., & Snyder, S. H. (1995). Nitric oxide: A neural messenger. Annual Review of Cell Development Biology, 11, 417-440.
16. Kuiper, M. A., Visser, J. J., Bergmans Paul, L. M., Scheltens, P., & Wolters, E. C. (1994). Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. Journal of Neurological Sciences, 121(1), 46-49.
17. Milstien, S., Sakai, N., Brew, B. J., Krieger, C., Vickers, J. H., Saito, K., & Heyes, M. P. (1994). Cerebrospinal fluid nitrite/nitrate levels in neurological diseases. Journal of Neurochemistry, 63(3), 1178-1180.
18. Mitchell, J. D., & Jackson, M. J. (1987). Indices of free radical activity in the cerebrospinal fluid in motor neurone disease. Journal of Neurology Neurosurgery Psychiatry, 50(7), 919-922.
19. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 351-358.
20. Pedersen, W. A., Fu, W., Keller, J. N., Markesbery, W. R., Appel, S. H., Smith, R. C., Kasarkis, E., & Mattson, M. P. (1998). Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Annals of Neurology, 44(5), 819-824.
21. Plaitakis, A., Smith, J., & Mandel, J. (1988). Pilot trial of branched-chain amino acids in amyotrophic lateral sclerosis. Lancet, 1(8593), 1015-1018.
22. Poduslo, J. F., Whelan, S. L., Curran, G. L., & Wengenack, T. M. (2000). Therapeutic benefit of polyamine modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics. Annals of Neurology, 48(6), 943-947.
23. Rhodes, P., Leone, A. M., Francis, P. L., Struthers, A. D., & Moncada, S. (1995). The Larginine: Nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochemistry Biophysics Research Communication, 209(2), 590-596.
24. Robberecht, W. (2000). Oxidative stress in amyotrophic lateral sclerosis. Journal of Neurology, 247(1), 11-16.
25. Sasaki, S., Shibata, N., Komori, T., & Iwata, M. (2000). iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neuroscience Letters, 291(1), 44-48.
26. Sayre, L. M., Smith, M. A., & Perry G. (2001). Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Current Medicinal Chemistry, 8(7), 721-738.
27. Schulz, J. B., Lindenau, J., Seyfried, J., & Dichgans, J. (2000). Glutathione, oxidative stress and neurodegeneration. European Journal of Biochemistry, 267(16), 4904-4911.
28. Sethi, S., Singh, M. P., & Dikshit, M. (1999). Nitric oxide mediated augmentation of polymorphonuclear free radical generation after hypoxia and reoxygenation. Blood, 93(1), 330-340.
29. Shaw, P. J., & Ince, P. G. (1997). Glutamate excitotoxicity and amyotrophic lateral sclerosis. Journal of Neurology, 244(2-3), 14.
30. Smith, R. G., Henry, Y. K., Mattson, M. P., & Appel, S. H. (1998). Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Annals of Neurology, 44(4), 696-699.
31. Szabo, C., Zingarelli, B., O'Connor, M., & Salzman, A. L. (1996). DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proceedings of National Academy of Sciences USA, 93(5), 1753-1758.
32. Taskiran, D., Sagduyu, A., Yuceyar, N., Kutay, F. Z., & Pogun, S. (2000). Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis. International Journal of Neuroscience, 101(1-4), 65-72.
33. Tohgi, H., Abe, T., Yamazaki, K., Murata, T., Ishizaki, E., & Isobe, C. (1999). Increase in oxidised NO products and reduction in oxidised glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neuroscience Letters, 260(3), 204-206.
34. Urushitani, M., Shimohama, S., Kihara, T., Sawada, H., Akaike, A., Ibi, M., Inoue, R., Kitamura, Y., Taniguchi, T., & Kimura, J. (1998). Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: Involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Annals of Neurology, 44(5), 796-807.
35. Wallerath, T., Gath, I., Aulitzky, W. E., Pollock, J. S., Kleinert, H., & Forstermann, U. (1997). Identification of nitric oxide synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thrombosis Haemostasis. 77(1), 163-176.
36. Wilms, H., Rosensteil, P., Sievers, J., Deuschi, G., & Lucius, R. (2001). Cerebrospinal fluid from patients with neurodegenerative and neuroinflammatory diseases: No evidence for rat glial activation in vitro. Neuroscience Letters, 314(3), 107-110.
37. World Federation of Neurology Research Group on Neuromuscular Diseases. (1994). El Escorial World Federation of Neurology Criteria for the diagnosis of amyotrophic lateral sclerosis. Journal of Neurological Sciences, 124 (Suppl), 96-107.